Natural adjuvants: Endogenous activators of dendritic cellsStefania Gallucci, Polly Matzinger, Martijn P. Lolkema|Nature Medicine|1999Cited by 1.6k
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial CarcinomaJ. Alberto Nakauma-González, Joost L. Boormans, Sandra van Wilpe et al.|European Urology|2022Cited by 46
Molecular characterization reveals genomic and transcriptomic subtypes of metastatic urothelial carcinomaJ. Alberto Nakauma-González, Joost L. Boormans, Maud Rijnders et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 4
Modular phase I/II clinical trial evaluating the selective MET-kinase inhibitor OMO-1 in patients with advanced malignancies: Safety and proof of mechanism.Martijn P. Lolkema, Sarah P. Blagden, Elizabeth Ruth Plummer et al.|Journal of Clinical Oncology|2019Cited by 1